International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients

Author(s): Muller George, Case Tyler, Deen Griffin L

Issue: Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide
View All Articles in Issue

Page(s): 395-399

Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Page 1

Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Page 2

Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Page 3

Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Page 4

Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Page 5

Download in electronic PDF format for $75

Abstract: An extreme gag reflex renders prophylactic dental care and undergoing operative dental procedures impossible for many people. Commercially available oral spray and lozenge anesthetics have an unpleasant taste and provide an insufficient duration of anesthesia. Compounded flavored tetracaine lollipops are an excellent alternative to other oral anesthetics and have enabled the treatment of many patients who have a strong aversion to dental care. In this report, we describe the use of that preparation in such patients. A formulation for tetracaine lollipops 0.5% is included.

Related Keywords: gag reflex, dentistry, oral anesthetic, tetracaine, topical administration, transbuccal absorption, mouth pain, analgesia, analgesic, pain relief, aphthous ulcers, formulation

Related Categories: DENTAL, FORMULATIONS, PAIN MANAGEMENT, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Muller George, Case Tyler, Deen Griffin L	Sep/Oct 2010 Pg. 395-399
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel Allen Loyd V Jr	May/Jun 2008 Pg. 266
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Bassani August S, Keim David	Nov/Dec 2004 Pg. 436-440
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers Young Jennifer L, Bogner Robin H	May/Jun 2009 Pg. 214-217
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Zur Eyal	Nov/Dec 2012 Pg. 462-469
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Zugerman Jessie Jean M, Reed Thomas C	Nov/Dec 2007 Pg. 514-519
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Mar/Apr 2024 Pg. 111-116
Safe Use of Topical Local Anesthetic Medications for Pain Management Epshteyn Mikhail G, Pepin Steven M	Mar/Apr 2024 Pg. 118-119
Safe Use of Topical Local Anesthetic Medications for Pain Management Epshteyn Mikhail G, Pepin Steven M	May/Jun 2009 Pg. 218-219
Current Concepts in the Treatment of Recurrent Aphthous Ulcers Bramwell Bethany L, Williams LaVonn A	Jan/Feb 2011 Pg. 13-18
Tetracaine 0.025% Popsicles Allen Loyd V Jr	Jan/Feb 2009 Pg. 73
Electrolyte Lollipop (Adult) Allen Loyd V Jr	Jan/Feb 2009 Pg. 70
Compounded Local Anesthetics to Minimize Pain from Medical Procedures McElhiney Linda F	May/Jun 2008 Pg. 192-197
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 513
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H	Mar/Apr 2018 Pg. 172-175
Tetracaine 4% and Menthol 5% Topical Gel Allen Loyd V Jr	Jan/Feb 2010 Pg. 73
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Return to Top